Swiss National Bank
SGMO

Swiss National Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Swiss National Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-300,660
Closed -$529K – 2651
2023
Q1 		$529K Sell
300,660
-20,600
-6% -$58.8K ﹤0.01% 2509
2022
Q4 		$1.01M Buy
321,260
+28,500
+10% +$111K ﹤0.01% 2339
2022
Q3 		$1.44M Hold
292,760
– – ﹤0.01% 2103
2022
Q2 		$1.21M Hold
292,760
– – ﹤0.01% 2258
2022
Q1 		$1.7M Buy
292,760
+22,600
+8% +$134K ﹤0.01% 2126
2021
Q4 		$2.03M Hold
270,160
– – ﹤0.01% 2052
2021
Q3 		$2.43M Buy
270,160
+1,800
+0.7% +$17.8K ﹤0.01% 1925
2021
Q2 		$3.21M Sell
268,360
-6,300
-2% -$71.3K ﹤0.01% 1793
2021
Q1 		$3.44M Buy
274,660
+3,300
+1% +$44.5K ﹤0.01% 1685
2020
Q4 		$4.24M Hold
271,360
– – ﹤0.01% 1465
2020
Q3 		$2.56M Buy
271,360
+12,600
+5% +$136K ﹤0.01% 1592
2020
Q2 		$2.32M Buy
258,760
+33,900
+15% +$315K ﹤0.01% 1634
2020
Q1 		$1.43M Buy
224,860
+3,400
+2% +$25.2K ﹤0.01% 1644
2019
Q4 		$1.85M Buy
221,460
+5,100
+2% +$46.9K ﹤0.01% 1773
2019
Q3 		$1.96M Buy
216,360
+6,000
+3% +$67.3K ﹤0.01% 1664
2019
Q2 		$2.27M Buy
210,360
+24,300
+13% +$258K ﹤0.01% 1620
2019
Q1 		$1.77M Buy
186,060
+6,300
+4% +$64.3K ﹤0.01% 1735
2018
Q4 		$2.06M Buy
179,760
+2,700
+2% +$33.5K ﹤0.01% 1548
2018
Q3 		$3M Buy
177,060
+3,900
+2% +$59.3K ﹤0.01% 1447
2018
Q2 		$2.46M Buy
173,160
+27,800
+19% +$462K ﹤0.01% 1562
2018
Q1 		$2.76M Buy
145,360
+2,900
+2% +$62K ﹤0.01% 1432
2017
Q4 		$2.34M Buy
142,460
+5,400
+4% +$80.3K ﹤0.01% 1538
2017
Q3 		$2.06M Sell
137,060
-6,500
-5% -$71.9K ﹤0.01% 1605
2017
Q2 		$1.26M Buy
143,560
+30,000
+26% +$192K ﹤0.01% 1889
2017
Q1 		$591K Hold
113,560
– – ﹤0.01% 2308
2016
Q4 		$346K Hold
113,560
– – ﹤0.01% 2493
2016
Q3 		$526K Hold
113,560
– – ﹤0.01% 2335
2016
Q2 		$658K Hold
113,560
– – ﹤0.01% 2204
2016
Q1 		$663K Buy
113,560
+21,400
+23% +$128K ﹤0.01% 2152
2015
Q4 		$841K Hold
92,160
– – ﹤0.01% 1948
2015
Q3 		$520K Buy
92,160
+13,100
+17% +$108K ﹤0.01% 2164
2015
Q2 		$877K Hold
79,060
– – ﹤0.01% 1872
2015
Q1 		$1.24M Buy
79,060
+2,000
+3% +$30.9K ﹤0.01% 1624
2014
Q4 		$1.17M Buy
77,060
+2,300
+3% +$27.9K ﹤0.01% 1642
2014
Q3 		$806K Hold
74,760
– – ﹤0.01% 1795
2014
Q2 		$1.14M Hold
74,760
– – ﹤0.01% 1638
2014
Q1 		$1.35M Buy
74,760
+19,360
+35% +$373K 0.01% 1497
2013
Q4 		$770K Hold
55,400
– – ﹤0.01% 1722
2013
Q3 		$581K Buy
55,400
+3,100
+6% +$30.8K ﹤0.01% 1838
2013
Q2 		$408K Buy
+52,300
New +$456K ﹤0.01% 2054

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swiss National Bank's SGMO Position: Q2 2023 in Review

Swiss National Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 300,660 shares — an estimated $529K sold.

Swiss National Bank first reported a position in SGMO in Q2 2013 and held it in 40 quarters. The position peaked at $4.24M in Q4 2020. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • Swiss National Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • Swiss National Bank sold 300,660 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $529K.
  • Swiss National Bank first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 40 quarters.
  • Swiss National Bank's SANGAMO THERAPEUTICS INC position peaked at $4.24M in Q4 2020.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.